Thus, while previous studies showed a correlation between DUSP4 expression and MEK inhibitor sensitivity in pan-tumour cell line panels,53 we report for the first time that this association exists in clinical melanomas, and depleting DUSP4 expression induces resistance to MEK inhibition. Here, MAP2K7 is linked to neoplasm.